NASDAQ: PTGX · Health Care / Biotechnology: Pharmaceutical Preparations

Protagonist Therapeutics Inc.

How Protagonist Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$9.3B
Price
$144.34
P/E
112.6
EPS (TTM)
$1.28
1-year return
88.2%
Dividend yield
0.0%
52-week range
$84.20–$144.88

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources